Inventors with similar research interests:
Location History:
- Sagamihara, JP (2001 - 2003)
- Shiroyama-Machi, JP (2002 - 2006)
- Tsukui-gun, JP (2006)
- Kai, JP (2008)
- Machida, JP (2008)
- Tokyo-To, JP (2006 - 2009)
- Minato-Ku, JP (2009)
- Nirasaki, JP (2012)
- Oshu, JP (2014 - 2018)
- Kamakura, JP (2015 - 2018)
- Iwate, JP (2017 - 2019)
- Kanagawa, JP (2000 - 2024)
Company Filing History:
27 out of 3,477 
26 out of 10,341 
3 out of 189 Years Active: 2000-2025
Areas of Expertise:
Title: Takanori Saito: Innovator in Cancer Treatment
Introduction
Takanori Saito, based in Kanagawa, Japan, is a distinguished inventor with an impressive portfolio of 57 patents to his name. His innovative research primarily focuses on pharmaceutical compositions aimed at the treatment and prevention of cancer.
Latest Patents
Among Saito's latest contributions to the field are groundbreaking patents concerning a pharmaceutical composition for cancer therapy. These patents detail an antibody or its fragment that exhibits immunoreactivity to a polypeptide featuring at least seven continuous amino acids derived from the CD179b protein. This protein has been identified as a cancer antigen specifically expressed on the surfaces of cancer cells, thereby positioning Saito's work at the forefront of cancer research.
Career Highlights
Throughout his career, Takanori Saito has worked with prominent companies such as Toray Industries, Inc. and Tokyo Electron Limited. His extensive experience in respected organizations has significantly enriched his understanding of innovative technologies and their application in the pharmaceutical sector.
Collaborations
Saito has collaborated with esteemed colleagues, including Fumiyoshi Okano and Shinichi Kobayashi. These partnerships have enabled the exchange of ideas and fostered advancements in their joint research endeavors.
Conclusion
Takanori Saito stands out as a notable inventor whose contributions in the realm of cancer treatment are paving the way for new therapeutic strategies. His relentless pursuit of innovation and collaboration within the industry highlights the essential role that dedicated inventors play in addressing critical health challenges.